Nephron analyst Thomas DeBourcy upgraded Azenta, Inc. (NASDAQ: AZTA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE